S395 Cold vs Hot Snare Endoscopic Mucosal Resection for Large Nonpedunculated Colorectal Polyps: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Introduction: Endoscopic mucosal resection (EMR) is pivotal in managing large nonpedunculated colorectal polyps (LNPCPs). While hot snare EMR (HS-EMR) is traditionally favored for its lower recurrence rates, cold snare EMR (CS-EMR) has attracted interest due to its superior safety profile. We aimed to compare CS-EMR and HS-EMR in terms of efficacy and safety outcomes for the removal of LNPCPs. Methods: We systematically searched PubMed, Embase, and Cochrane databases through February 2025 to identify randomized controlled trials comparing CS-EMR with HS-EMR in LNPCPs. Recurrence rate and safety profile were the outcomes of interest. Data were pooled using random-effects models with subgroup analyses based on polyp size and histologic subtype. Results: Four studies were included in the meta-analysis. Of these, 3 were full-text articles and one was an abstract. Three studies examined colorectal polyps larger than 20 mm, while 1 study included polyps larger than 15 mm. In this study, the median polyp size was 30 mm (interquartile range 25-35). A total of 1,429 patients and 1,516 polyps were included. Of these, 722 patients (50.5%) and 766 polyps (50.5%) underwent CS-EMR. The risk of recurrence in the CS-EMR was significantly higher (≥15 mm: risk ratio [RR] 2.02, 95% confidence interval [CI] 1.44-2.84; ≥20 mm: RR 1.91, 95% CI 1.50-2.43). The subgroup including adenomatous polyps showed similar trends (≥15 mm: RR 2.05, 95% CI 1.38-3.03; ≥20 mm: RR 1.93, 95% CI 1.49-2.50), whereas the risk of recurrence in sessile serrated polyps (SSP) did not differ significantly (≥20 mm: RR 2.00, 95% CI 0.59-6.79). Safety outcomes favored CS-EMR, with lower risks of perforation (RR 0.11, 95% CI 0.02-0.63), postprocedural bleeding (RR 0.34, 95% CI 0.13–0.88), and clip closure (RR 0.35, 95% CI 0.16-0.78), while intraprocedural bleeding (RR 0.58, 95% CI 0.30-1.10) and postpolypectomy syndrome (RR 0.60, 95% CI 0.24-1.46) were similar. Conclusion: Our meta-analysis shows that CS-EMR offers a safer profile with significantly lower perforation and postprocedural bleeding rates in the removal of LNPCPs. As for the recurrence risk, it is higher with CS-EMR compared to HS-EMR for the large nonpedunculated adenomatous polyps, while it did not reach statistical significance for sessile serrated polyps. These findings support current guidelines favoring HS-EMR for large nonpedunculated adenomatous polyps while highlighting that CS-EMR may be a viable alternative in select clinical scenarios.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001129040.43529.df
Primary Topic
Gastric Cancer Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S395 Cold vs Hot Snare Endoscopic Mucosal Resection for Large Nonpedunculated Colorectal Polyps: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Stefan Mitev, Nazlı Begüm Öztürk, Ali Emre Bardak, Kavin Kanthasamy et al.
The American Journal of Gastroenterology
Gastric Cancer Management and Outcomes
article

S395 Cold vs Hot Snare Endoscopic Mucosal Resection for Large Nonpedunculated Colorectal Polyps: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Stefan Mitev, Nazlı Begüm Öztürk, Ali Emre Bardak, Kavin Kanthasamy, Merve Gürakar, Yusuf Yalcin, Saqr Alsakarneh, Gizem Teker
article en

Abstract

Introduction: Endoscopic mucosal resection (EMR) is pivotal in managing large nonpedunculated colorectal polyps (LNPCPs). While hot snare EMR (HS-EMR) is traditionally favored for its lower recurrence rates, cold snare EMR (CS-EMR) has attracted interest due to its superior safety profile. We aimed to compare CS-EMR and HS-EMR in terms of efficacy and safety outcomes for the removal of LNPCPs. Methods: We systematically searched PubMed, Embase, and Cochrane databases through February 2025 to identify randomized controlled trials comparing CS-EMR with HS-EMR in LNPCPs. Recurrence rate and safety profile were the outcomes of interest. Data were pooled using random-effects models with subgroup analyses based on polyp size and histologic subtype. Results: Four studies were included in the meta-analysis. Of these, 3 were full-text articles and one was an abstract. Three studies examined colorectal polyps larger than 20 mm, while 1 study included polyps larger than 15 mm. In this study, the median polyp size was 30 mm (interquartile range 25-35). A total of 1,429 patients and 1,516 polyps were included. Of these, 722 patients (50.5%) and 766 polyps (50.5%) underwent CS-EMR. The risk of recurrence in the CS-EMR was significantly higher (≥15 mm: risk ratio [RR] 2.02, 95% confidence interval [CI] 1.44-2.84; ≥20 mm: RR 1.91, 95% CI 1.50-2.43). The subgroup including adenomatous polyps showed similar trends (≥15 mm: RR 2.05, 95% CI 1.38-3.03; ≥20 mm: RR 1.93, 95% CI 1.49-2.50), whereas the risk of recurrence in sessile serrated polyps (SSP) did not differ significantly (≥20 mm: RR 2.00, 95% CI 0.59-6.79). Safety outcomes favored CS-EMR, with lower risks of perforation (RR 0.11, 95% CI 0.02-0.63), postprocedural bleeding (RR 0.34, 95% CI 0.13–0.88), and clip closure (RR 0.35, 95% CI 0.16-0.78), while intraprocedural bleeding (RR 0.58, 95% CI 0.30-1.10) and postpolypectomy syndrome (RR 0.60, 95% CI 0.24-1.46) were similar. Conclusion: Our meta-analysis shows that CS-EMR offers a safer profile with significantly lower perforation and postprocedural bleeding rates in the removal of LNPCPs. As for the recurrence risk, it is higher with CS-EMR compared to HS-EMR for the large nonpedunculated adenomatous polyps, while it did not reach statistical significance for sessile serrated polyps. These findings support current guidelines favoring HS-EMR for large nonpedunculated adenomatous polyps while highlighting that CS-EMR may be a viable alternative in select clinical scenarios.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 56%
Gastric Cancer Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.